Every material Form 8-K Avery Dennison filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Avery Dennison said Chief Financial Officer Gregory Lovins began a medical leave of absence on November 14, 2024, and ceased serving as principal financial officer as of that date. The Board named Senior Vice President and Chief Strategy and Corporate Development Officer Danny G. Allouche as interim CFO, effective November 15, 2024, and he will keep his current role.
Gregory S. Lovins began a medical leave of absence on November 14, 2024.
Danny G. Allouche, age 50, was elected Senior Vice President and Interim Chief Financial Officer effective November 15, 2024.
The filing does not state how long the interim appointment will last.
Allouche's compensation is unchanged: base salary of ILS 1,680,000 (about $450,000), 50% target annual incentive and 120% target long-term incentive.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Avery Dennison filing is on SEC EDGAR ↗. 8-K briefs of other companies →